Anders Niklason
About
In The Last Decade
Anders Niklason
8 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cardiology and Cardiovascular Medicine 1.4k
- Endocrinology, Diabetes and Metabolism 905
- Pharmacology 282
- Surgery 199
- Physiology 174
Countries citing papers authored by Anders Niklason
This map shows the geographic impact of Anders Niklason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Niklason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Niklason more than expected).
Fields of papers citing papers by Anders Niklason
This network shows the impact of papers produced by Anders Niklason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Niklason. The network helps show where Anders Niklason may publish in the future.
Co-authorship network of co-authors of Anders Niklason
This figure shows the co-authorship network connecting the top 25 collaborators of Anders Niklason. A scholar is included among the top collaborators of Anders Niklason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Niklason. Anders Niklason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 22 | |
| 3 | 6 | |
| 4 | 71 | |
| 5 | 40 | |
| 6 | 149 | |
| 7 | Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial breakdown → | 1480 |
| 8 | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.